Latest treatment of multiple sclerosis Stories
Part 1: Overview, progress toward stopping MS. New York, NY (PRWEB) December 27, 2012 MS research continued to advance on many fronts in 2012.
A new drug to fight multiple sclerosis (MS) is showing promise as one of the “most effective” treatment options ever produced for the debilitating disease, according to UK researchers.
A widely prescribed MS treatment may not be as effective in the long term as some would have hoped. New research shows that there’s no strong evidence that a group of drugs, beta interferons (ß-IFNs), prescribed to treat MS, had a measurable impact on the long-term disability progression of the disease.
Among patients with relapsing-remitting multiple sclerosis (MS), treatment with the widely-prescribed drug to treat MS, interferon beta, was not associated with less progression of disability.
Research conducted by Jesus Lovera, MD, Assistant Professor of Neurology at LSU Health Sciences Center New Orleans, and colleagues has shown that stress management treatment significantly reduced the formation of new brain lesions in people with multiple sclerosis (MS) over the course of treatment.
The first large non-commercial study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS) shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale.
A new study finds that smoked cannabis can provide relief from pain and muscular tightness - otherwise known as spasticity – in people with multiple sclerosis at the risk of adverse cognitive effects.
According to a recent study, people who received injections of the multiple sclerosis (MS) drug interferon beta-1a directly after noticing signs of possible MS were less likely to progress into definite MS compared to those who switched to interferon beta-1a from placebo.
- totally perplexed and mixed up.